Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells

Overview of attention for article published in Frontiers in Cell and Developmental Biology, August 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 9 Mendeley

Summary X Patents

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION THERAPY USING A MALT1 INHIBITOR AND A BTK INHIBITOR

Application WO-2022184716-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.